Related Experiment Video
Updated: Jun 5, 2025

Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis
Published on: February 2, 2021
Combined quantitative analysis of the nigro-striata system in multiple system atrophy and Parkinson's disease
Mai Hatanaka1, Kazuhiro Hara1, Chisato Ohba1
1Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho Showa-ku, Nagoya 466-8550, Japan.
Abstract:
Degeneration of the nigrostriatal system occurs in multiple system atrophy (MSA) and Parkinson's disease (PD) via distinct pathological mechanisms. Here, we investigated nigrostriatal degeneration in MSA and PD by combining a newly developed method for evaluating the regional accumulation of dopamine transporter single-photon emission computed tomography (DAT SPECT) and individual voxel-based morphometry adjusting covariates (iVAC). We recruited 17 MSA patients and 13 PD patients, and compared their clinical and imaging indices. All patients underwent DAT SPECT and head three-dimensional T1-weighted magnetic resonance imaging. We calculated the specific binding ratio (SBR) of the putamen and caudate separately using a region-based method, and evaluated the association between the SBR and iVAC Z-score. SBR values of the putamen and caudate were lower in the PD group than in the MSA group (p < 0.001 for both). The MSA and PD groups had lower SBR values in the putamen than in the caudate (p < 0.05 and p < 0.001, respectively). We found a negative correlation between the putamen SBR and iVAC Z-score in MSA (p < 0.001, r = -0.775), but such a correlation was not detected in PD. For the caudate, there was no correlation between the SBR and iVAC Z-score in MSA and PD. Our results indicate different mechanisms of reduced uptake of DATs in MSA and PD. The association between the striatal SBR and iVAC Z-score suggests parallel degeneration in the substantia nigra and striatum in MSA.
Related Concept Videos
Neural Regulation
Parkinson's Disease: Overview

